Fig. 4From: Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patientsPicture showing the potential role of the identified genes in the development of cell-autonomous and non–cell-autonomous resistance to antineoplastic agents, according to literature data. Created with BioRender.comBack to article page